Physician scientist
Unaffiliated
Dr. Dahlin is currently a physician scientist at Agios Pharmaceuticals. He previously served as a consultant at the National Center for Advancing Translational Sciences, where he performed chemical biology and translational medicine research. Dr. Dahlin completed a clinical residency in Clinical Pathology at Brigham and Women's Hospital/Harvard Medical School, and a postdoctoral fellowship in chemical biology at the Broad Institute with Dr. Stuart Schreiber. He received his M.D. and Ph.D. from the Mayo Clinic. He has published extensively on chemical mechanisms of compound-mediated assay interferences.